- Home
- TMHC vs ELAN Comparison
TMHC vs ELAN Comparison
Compare TMHC & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMHC
- ELAN
- Stock Information
- Founded
- TMHC 1936
- ELAN 1954
- Country
- TMHC United States
- ELAN United States
- Employees
- TMHC N/A
- ELAN N/A
- Industry
- TMHC Homebuilding
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- TMHC Consumer Discretionary
- ELAN Health Care
- Exchange
- TMHC Nasdaq
- ELAN Nasdaq
- Market Cap
- TMHC 7.2B
- ELAN 6.3B
- IPO Year
- TMHC 2013
- ELAN 2018
- Fundamental
- Price
- TMHC $70.23
- ELAN $13.97
- Analyst Decision
- TMHC Buy
- ELAN Buy
- Analyst Count
- TMHC 8
- ELAN 6
- Target Price
- TMHC $77.33
- ELAN $17.00
- AVG Volume (30 Days)
- TMHC 959.1K
- ELAN 4.5M
- Earning Date
- TMHC 10-23-2024
- ELAN 11-07-2024
- Dividend Yield
- TMHC N/A
- ELAN N/A
- EPS Growth
- TMHC N/A
- ELAN N/A
- EPS
- TMHC 7.54
- ELAN 0.41
- Revenue
- TMHC $7,831,512,000.00
- ELAN $4,454,000,000.00
- Revenue This Year
- TMHC $6.42
- ELAN $2.22
- Revenue Next Year
- TMHC $7.33
- ELAN $2.77
- P/E Ratio
- TMHC $9.28
- ELAN $33.88
- Revenue Growth
- TMHC N/A
- ELAN 1.99
- 52 Week Low
- TMHC $44.32
- ELAN $11.40
- 52 Week High
- TMHC $74.69
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- TMHC 51.11
- ELAN 56.31
- Support Level
- TMHC $69.47
- ELAN $12.35
- Resistance Level
- TMHC $74.69
- ELAN $14.71
- Average True Range (ATR)
- TMHC 2.26
- ELAN 0.49
- MACD
- TMHC -0.09
- ELAN 0.19
- Stochastic Oscillator
- TMHC 52.31
- ELAN 67.29
About TMHC Taylor Morrison Home Corporation
Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities. It designs, builds and sells single and multi-family detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. The company has four reportable segments: East, Central, West and Financial Services. The majority of the company's revenue is derived from its East Segment.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.